dOSe — Peptide Tracker
dOSe is a specialized peptide tracking app for researchers and self-optimizers on iOS.
The App DNA
What makes this app unique?
It removes the cognitive and mathematical friction of managing complex peptide protocols and vial inventory, displacing manual spreadsheets and note-taking apps.
For Researchers and self-optimizers managing complex peptide protocols who require precise dosing and inventory management.
What does it look like?
Key features
Calculates exact draw amounts based on vial contents, bacteriostatic water volume, and syringe size.
Tracks vial status from purchase to reconstitution and expiration.
Database of 50+ compounds with research profiles.
How much does it cost?
Freemium model gates advanced analytics, library access, and cloud sync behind a subscription anchored at $49.99/year.
Velocity
Dormant developmentopaqueShow more...
With only one release shipped since launch and no activity in the last 133 days, the development momentum is classified as a zombie state. The app has not received any updates, feature additions, or maintenance patches since its debut. There is no evidence of active development or ongoing support for the platform.
Who built it?
User Sentiment
What do users think recently?
Recent user voice shows a thrilled sentiment. Users appreciate peptide-focused tracking functionality provides helpful utility for users managing their specific health and wellness regimens.
How are ratings & reviews evolving?
What users say, by theme
- Peptide-focused tracking functionality provides helpful utility for users managing their specific health and wellness regimens
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for dOSe — Peptide Tracker
How's the Health & Fitness market?
dOSe occupies a specialized niche in the Health & Fitness category, focusing on peptide-specific utility rather than general wellness. The lack of updates over the last 133 days suggests a maintenance-mode posture that limits its ability to compete with more active health-tracking entrants.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for dOSe — Peptide Tracker
Where is it heading?
The peptide-tracking market remains a niche segment where utility-focused tools like dOSe hold an advantage over generalist apps. However, the current maintenance-mode cadence leaves dOSe exposed to competitors who may introduce more frequent feature iterations, necessitating a shift toward conversion optimization to sustain the business.
- The four-month update gap indicates a dormant development cycle, which limits the ability to respond to user feedback or market shifts.
- The specialized utility of the reconstitution calculator provides a defensible moat against general-purpose health trackers that lack peptide-specific logic.
The SWOT
- Reconstitution calculator removes manual conversion error
- Inventory tracking creates recurring usage loop
- Localized protocol templates for specific research goals
- Integration with wearable health data for correlation
Next best moves
Ship a free-to-use trial period for the Peptide Library because the lack of a trial is a conversion barrier → increase subscription conversion
+ 1 more prioritized moveThe counter-intuitive read
The lack of updates is not just a weakness…
Read the full takeBottom line
dOSe provides a high-utility tool for peptide researchers, but the current lack of development velocity risks ceding the niche to more active competitors. Focusing on conversion optimization through trial periods would unlock revenue from the existing user base while the team evaluates a more sustainable update cadence.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated